+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Xanthan Gum for Pharmaceutical Market by Formulation (Liquid Formulations, Semi Solid Formulations, Solid Formulations), Application (Binding, Controlled Release, Emulsification), Product Grade, End User, Sales Channel - Global Forecast 2025-2030- Product Image
Xanthan Gum for Pharmaceutical Market by Formulation (Liquid Formulations, Semi Solid Formulations, Solid Formulations), Application (Binding, Controlled Release, Emulsification), Product Grade, End User, Sales Channel - Global Forecast 2025-2030- Product Image
New

Xanthan Gum for Pharmaceutical Market by Formulation (Liquid Formulations, Semi Solid Formulations, Solid Formulations), Application (Binding, Controlled Release, Emulsification), Product Grade, End User, Sales Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6120675
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Xanthan gum has emerged as a cornerstone excipient in pharmaceutical formulation, prized for its exceptional viscosity-enhancing, stabilizing, and suspension properties. Initially discovered through microbial fermentation, this polysaccharide has transcended legacy uses to become integral in modern drug delivery systems. Beyond imparting rheological control, xanthan gum offers the flexibility needed for a broad spectrum of dosage forms, from oral suspensions that ease patient adherence to topical gels that deliver active ingredients with precision.

The inherent compatibility of xanthan gum with both hydrophilic and lipophilic compounds underpins its versatility. As drug developers increasingly prioritize complex molecules and biologics, the excipient’s role in maintaining formulation integrity under varying pH and temperature conditions is more critical than ever. Consequently, stakeholders across the pharmaceutical value chain-from research laboratories to contract manufacturers-are deepening their focus on sourcing high-purity grades and optimizing processing protocols to harness these unique functional benefits.

As we embark on this executive summary, our intent is to illuminate the transformative factors reshaping xanthan gum utilization in pharmaceuticals, spotlight emerging segmentation dynamics, regional variances, and strategic imperatives that industry leaders must address to secure a competitive edge.

Illuminating the Convergence of Sustainable Bioprocessing and Precision Delivery Fueling the Next Generation of Pharmaceutical Excipients

Over recent years, the pharmaceutical landscape has witnessed paradigm shifts driven by personalized medicine, biologic therapies, and digital innovation. In this evolving environment, excipients like xanthan gum play pivotal roles far beyond mere thickening agents. Consequently, developers are integrating novel delivery concepts such as controlled-release injectables and transdermal patches, where precise viscosity modulation is essential for patient-centric dosing and sustained efficacy.

Simultaneously, sustainability mandates and green chemistry principles are inspiring manufacturers to optimize fermentation methods, reduce energy consumption, and valorize fermentation residues. This has propelled the adoption of bio-based production technologies, which not only align with regulatory expectations for environmental stewardship but also enhance traceability and supply chain resilience. As material science converges with data-driven process optimization, we find that digital twin simulations and real-time monitoring are unlocking new avenues for consistent, high-quality excipient production.

By recognizing these transformative shifts-from formulation innovation to sustainable manufacturing-stakeholders can reposition their operations, fortify strategic partnerships, and invest in capabilities that anticipate the next wave of pharmaceutical advancements.

Examining How the 2025 Tariff Regime Has Catalyzed Supplier Diversification and Localized Biopolymer Production Strategies

The imposition of cumulative tariffs by the United States in 2025 has exerted significant pressure on global supply chains for pharmaceutical-grade materials. As duties on imported raw materials increased, sourcing strategies shifted markedly toward regional production hubs capable of meeting stringent quality requirements without the added tariff burden. Consequently, manufacturers recalibrated procurement models, emphasizing supplier diversification to mitigate geo-political uncertainties.

In response, several stakeholders accelerated investments in local production and backward integration, establishing fermentation and purification facilities within duty-free zones. This geographic realignment fostered closer collaboration between excipient suppliers and pharmaceutical formulators, streamlining logistics and reducing lead times. Moreover, elevated import costs triggered broader cost-control initiatives, compelling companies to adopt lean manufacturing methodologies and negotiate longer-term supply agreements anchored by volume-based incentives rather than spot purchases.

Through this lens, we observe that the tariff environment has prompted a strategic reorientation toward network resiliency, transparent cost structures, and agile supply chain frameworks. These adaptations ensure that excipient availability aligns with dynamic formulation demands while insulating manufacturers from future trade policy uncertainties.

Unpacking Multidimensional Pharmaceutical Formulation and Distribution Segmentation Reveals Strategic Pathways for Value Creation

Segmentation analysis reveals that formulation-based distinctions critically inform product development and commercialization strategies. Manufacturers segment liquid, semi-solid, and solid dosage forms, tailoring xanthan gum grades to meet unique viscosity and stability requirements across injectable suspensions, oral suspensions, creams, gels, ointments, capsules, and tablets. Parallel application-driven segmentation underscores the importance of binding, controlled-release matrices, emulsification, stabilizing, and thickening functions, each dictating precise excipient specifications.

Investigation into product grade segmentation highlights that adherence to EP, JP, and USP standards ensures regulatory compliance and consistent performance, with each pharmacopeial grade commanding specific manufacturing protocols. End-user segments further differentiate between branded drug innovators, contract manufacturers catering to diversified pipelines, and generic producers focused on cost-efficiency. Finally, sales channels diversify into direct engagements with key accounts, distributor networks that extend market reach, and digital platforms enabling rapid order fulfillment. Taken together, these segmentation dimensions offer a multidimensional framework for mapping competitive positions, identifying unmet needs, and directing R&D priorities toward high-value formulation niches.

Mapping Regional Regulatory, Manufacturing, and Partnership Dynamics That Drive Xanthan Gum Utilization Across Global Pharmaceutical Hubs

Regional dynamics play a decisive role in shaping xanthan gum adoption, as each geography presents distinct regulatory regimes, supply chain footprints, and therapeutic demands. Within the Americas, robust pharmaceutical manufacturing centers leverage integrated supply networks, fostering close alignment between excipient suppliers and leading drug developers. Latin America’s growing emphasis on biosimilars and generics is intensifying demand for stabilizing agents, accelerating technology transfer initiatives.

Shifting focus to Europe, the Middle East, and Africa, diverse regulatory frameworks demand excipient traceability and adherence to stringent quality benchmarks. In Western Europe, established players prioritize green manufacturing and compliance, while emerging markets in the region are exploring partnership models to localize production. Meanwhile, the Gulf and North African markets are poised for expansion as healthcare infrastructure investments drive new formulation pipelines.

In the Asia-Pacific region, rapid growth in both generics and novel drug research has spurred demand for high-performance excipients. Leading markets in East Asia and Oceania invest heavily in R&D and process innovation, whereas Southeast Asia emphasizes accessible formulations to meet expanding patient populations. Across these regions, stakeholders are forging strategic alliances to optimize supply continuity, leverage cost-competitive manufacturing bases, and navigate complex regulatory landscapes effectively.

Investigating Strategic Collaborations, Digital Quality Initiatives, and Fermentation Innovations Shaping Leading Excipients Suppliers

Industry leaders have distinguished themselves through targeted investments in proprietary fermentation technologies and advanced purification platforms. Key excipient producers have forged strategic alliances with biotechnology firms to develop next-generation microbial strains that deliver higher yields and reduced impurity profiles. In parallel, several companies have launched custom formulation services, embedding application experts within client teams to co-develop drug formulations that harness the full functional potential of xanthan gum.

Furthermore, forward-thinking organizations are integrating digital quality management systems that provide end-to-end traceability from raw material intake through final product release. This digitalization not only accelerates regulatory submissions but also enhances risk management and continuous improvement efforts. To support global expansion, select players have established regional manufacturing and distribution centers, ensuring timely delivery and local technical support. These strategic moves differentiate market participants, enabling them to respond swiftly to emerging therapeutic trends and regulatory changes while safeguarding operational excellence.

Actionable Strategies for Mitigating Trade Risks, Accelerating Green Bioprocessing, and Enhancing Customer-Centric Formulation Support

To navigate the evolving pharmaceutical excipients landscape, industry leaders should prioritize diversification of supply sources by establishing partnerships across multiple geographies, thereby reducing exposure to trade policy shifts. Concurrently, investing in green fermentation and continuous processing technologies will not only lower environmental impact but also enhance cost efficiencies and ensure consistent material quality. It is critical to integrate process analytical technologies and digital twins to enable real-time quality assurance and accelerate time-to-market for new formulation platforms.

Moreover, companies must deepen collaboration with formulation development teams, offering co-creation services that align excipient functionality with emerging drug modalities such as biologics and peptide-based therapies. Strengthening regulatory intelligence capabilities and engaging proactively with pharmacopoeial committees can streamline compliance pathways and preempt future standards. Lastly, leveraging direct digital sales channels and value-added distributor networks will fortify market access, while tailored technical support programs can cement long-term customer relationships and drive recurring revenue streams.

Detailing the Comprehensive Mixed-Methods Approach Employing Expert Consultations, Data Triangulation, and Statistical Validation

This study integrates a rigorous mixed-methods approach, beginning with in-depth consultations with industry experts across formulation development, supply chain management, and regulatory affairs. Complementary secondary research sources, including patent filings, academic journals, and industry white papers, provided contextual insights and historical benchmarks. To ensure data robustness, findings were triangulated through cross-validation with proprietary company disclosures, public filings, and global trade databases.

Quantitative analyses were performed on supplier capacity metrics, technology adoption rates, and regulatory approval timelines, with anomalies identified via statistical outlier detection. Qualitative inputs were synthesized through structured interviews, capturing nuanced perspectives on emerging formulation challenges and strategic responses. All data underwent stringent quality checks, including peer reviews by subject-matter experts and consistency audits. The methodology ensures that conclusions and strategic recommendations are grounded in both empirical evidence and firsthand operational intelligence.

Synthesizing Functional Excellence, Sustainable Production, and Market Dynamics to Chart the Future Trajectory of Pharmaceutical Excipients

Xanthan gum’s pivotal role in pharmaceutical formulation continues to expand as developers seek versatile excipients that support increasingly sophisticated drug delivery systems. From adaptive controlled-release injectables to patient-friendly topical formulations, this natural polymer offers a blend of functional attributes that bridge formulation science and patient experience imperatives. Simultaneously, sustainability and supply chain resilience have elevated the importance of localized production, digital quality oversight, and green bioprocessing innovations.

Navigating these dynamics requires a holistic understanding of segmentation nuances, regional market conditions, and leading supplier strategies. By aligning internal capabilities with external trends-whether regulatory shifts, tariff frameworks, or therapeutic breakthroughs-pharmaceutical stakeholders can secure their competitive position. Ultimately, the convergence of technological innovation, environmental stewardship, and customer-centric collaboration will define the next chapter in xanthan gum’s journey within the global pharmaceutical ecosystem.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Formulation
    • Liquid Formulations
      • Injectable Suspensions
      • Oral Suspensions
    • Semi Solid Formulations
      • Creams
      • Gels
      • Ointments
    • Solid Formulations
      • Capsules
      • Tablets
  • Application
    • Binding
    • Controlled Release
    • Emulsification
    • Stabilizing
    • Thickening
  • Product Grade
    • EP Grade
    • JP Grade
    • USP Grade
  • End User
    • Branded Manufacturers
    • Contract Manufacturers
    • Generic Manufacturers
  • Sales Channel
    • Direct Sales
    • Distributors
    • Online Platforms
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • CP Kelco ApS
  • Cargill, Incorporated
  • Fufeng Group Co., Ltd.
  • DuPont de Nemours, Inc.
  • Jungbunzlauer Suisse AG
  • Lamberti S.p.A.
  • Nexira SAS
  • Ashland Global Holdings Inc.
  • Zhejiang Juhua Co., Ltd.
  • Ingredion Incorporated

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of xanthan gum with lipid nanoparticles for targeted drug delivery in oncology
5.2. Advances in continuous fermentation processes for sustainable high-purity pharmaceutical-grade xanthan gum
5.3. Utilization of xanthan gum to enhance bioavailability in controlled-release oral dosage forms
5.4. Regulatory harmonization efforts impacting monograph specifications for pharmaceutical-grade xanthan gum globally
5.5. Development of xanthan gum-based hydrogel matrices for localized subcutaneous drug depots
5.6. Optimization of in-line process analytical technology for quality by design in xanthan gum production
5.7. Growth of plant-based alternative stabilizers driving demand for clean-label pharmaceutical excipients like xanthan gum
5.8. Impact of supply chain digitalization on traceability and compliance of xanthan gum in sterile injectable formulations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Xanthan Gum for Pharmaceutical Market, by Formulation
8.1. Introduction
8.2. Liquid Formulations
8.2.1. Injectable Suspensions
8.2.2. Oral Suspensions
8.3. Semi Solid Formulations
8.3.1. Creams
8.3.2. Gels
8.3.3. Ointments
8.4. Solid Formulations
8.4.1. Capsules
8.4.2. Tablets
9. Xanthan Gum for Pharmaceutical Market, by Application
9.1. Introduction
9.2. Binding
9.3. Controlled Release
9.4. Emulsification
9.5. Stabilizing
9.6. Thickening
10. Xanthan Gum for Pharmaceutical Market, by Product Grade
10.1. Introduction
10.2. EP Grade
10.3. JP Grade
10.4. USP Grade
11. Xanthan Gum for Pharmaceutical Market, by End User
11.1. Introduction
11.2. Branded Manufacturers
11.3. Contract Manufacturers
11.4. Generic Manufacturers
12. Xanthan Gum for Pharmaceutical Market, by Sales Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online Platforms
13. Americas Xanthan Gum for Pharmaceutical Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Xanthan Gum for Pharmaceutical Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Xanthan Gum for Pharmaceutical Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. CP Kelco ApS
16.3.2. Cargill, Incorporated
16.3.3. Fufeng Group Co., Ltd.
16.3.4. DuPont de Nemours, Inc.
16.3.5. Jungbunzlauer Suisse AG
16.3.6. Lamberti S.p.A.
16.3.7. Nexira SAS
16.3.8. Ashland Global Holdings Inc.
16.3.9. Zhejiang Juhua Co., Ltd.
16.3.10. Ingredion Incorporated
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. XANTHAN GUM FOR PHARMACEUTICAL MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. XANTHAN GUM FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. XANTHAN GUM FOR PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. XANTHAN GUM FOR PHARMACEUTICAL MARKET: RESEARCHAI
FIGURE 26. XANTHAN GUM FOR PHARMACEUTICAL MARKET: RESEARCHSTATISTICS
FIGURE 27. XANTHAN GUM FOR PHARMACEUTICAL MARKET: RESEARCHCONTACTS
FIGURE 28. XANTHAN GUM FOR PHARMACEUTICAL MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. XANTHAN GUM FOR PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY INJECTABLE SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY INJECTABLE SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY BINDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY BINDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY EMULSIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY EMULSIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY STABILIZING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY STABILIZING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY THICKENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY THICKENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY EP GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY EP GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY JP GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY JP GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY USP GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY USP GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY BRANDED MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY BRANDED MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 110. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 111. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 112. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 113. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 114. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 115. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 116. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 117. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 120. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 121. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. CANADA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 126. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 127. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 132. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 133. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. MEXICO XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 208. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 209. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 211. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 214. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 215. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. GERMANY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 224. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 225. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 230. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 231. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 235. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. FRANCE XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 256. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 257. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 258. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 259. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 260. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 261. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 262. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 263. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 266. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 267. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. ITALY XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 272. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 273. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 275. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 279. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 282. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 283. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SPAIN XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY LIQUID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SEMI SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES XANTHAN GUM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES X

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Xanthan Gum for Pharmaceutical market report include:
  • CP Kelco ApS
  • Cargill, Incorporated
  • Fufeng Group Co., Ltd.
  • DuPont de Nemours, Inc.
  • Jungbunzlauer Suisse AG
  • Lamberti S.p.A.
  • Nexira SAS
  • Ashland Global Holdings Inc.
  • Zhejiang Juhua Co., Ltd.
  • Ingredion Incorporated

Related Topics

Related Reports

Liquid Xanthan Gum Market by Application (Food & Beverage, Oil & Gas, Personal Care), Grade (Cosmetic Grade, Food Grade, Industrial Grade), Distribution Channel - Global Forecast 2025-2030 - Product Image

Liquid Xanthan Gum Market by Application (Food & Beverage, Oil & Gas, Personal Care), Grade (Cosmetic Grade, Food Grade, Industrial Grade), Distribution Channel - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Pharmaceutical Grade Xanthan Gum Market by Application (Food & Beverage, Oil & Gas, Personal Care), Grade (Industrial, Pharmaceutical, Standard), Form, Sales Channel, Packaging Type - Global Forecast 2025-2030 - Product Image

Pharmaceutical Grade Xanthan Gum Market by Application (Food & Beverage, Oil & Gas, Personal Care), Grade (Industrial, Pharmaceutical, Standard), Form, Sales Channel, Packaging Type - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Industrial Grade Xanthan Gum Market by Application (Cosmetics & Personal Care, Food & Beverage, Oil & Gas), Form (Granular, Liquid, Powder), Sales Channel - Global Forecast 2025-2030 - Product Image

Industrial Grade Xanthan Gum Market by Application (Cosmetics & Personal Care, Food & Beverage, Oil & Gas), Form (Granular, Liquid, Powder), Sales Channel - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Xanthan Gum Food Additives Market by Application (Food & Beverage, Oil & Gas, Personal Care & Cosmetics), Form (Liquid, Powder), Grade, Distribution Channel - Global Forecast 2025-2030 - Product Image

Xanthan Gum Food Additives Market by Application (Food & Beverage, Oil & Gas, Personal Care & Cosmetics), Form (Liquid, Powder), Grade, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Transparent Grade Xanthan Gum Market by Form (Emulsion, Liquid, Powder), Sales Channel (Direct Sales, Distributors, Online), Application, End User - Global Forecast 2025-2030 - Product Image

Transparent Grade Xanthan Gum Market by Form (Emulsion, Liquid, Powder), Sales Channel (Direct Sales, Distributors, Online), Application, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.